Neural stem cells (NSCs) have been proposed as a promising cellular source for the treatment of diseases in nervous systems. NSCs can self-renew and generate major cell types of the mammalian central nervous system throughout adulthood. NSCs exist not only in the embryo, but also in the adult brain neurogenic region: the subventricular zone (SVZ) of the lateral ventricle. Embryonic stem (ES) cells acquire NSC identity with a default mechanism. Under the regulations of leukemia inhibitory factor (LIF) and fibroblast growth factors, the NSCs then become neural progenitors. Neurotrophic and differentiation factors that regulate gene expression for controlling neural cell fate and function determine the differentiation of neural progenitors in the developing mammalian brain. For clinical application of NSCs in neurodegenerative disorders and damaged neurons, there are several critical problems that remain to be resolved: 1) how to obtain enough NSCs from reliable sources for autologous transplantation; 2) how to regulate neural plasticity of different adult stem cells; 3) how to control differentiation of NSCs in the adult nervous system. In order to understand the mechanisms that control NSC differentiation and behavior, we review the ontogeny of NSCs and other stem cell plasticity of neuronal differentiation. The role of NSCs and their regulation by neurotrophic factors in CNS development are also reviewed.
INTRODUCTION
oligodendrocytes (26, 101, 198) . The earliest neural cells are likely to be neural progenitors or stem cells (188). Stem cells in general are defined on the basis of two Neurogenesis in the adult brain relies on neural stem cells (NSCs) (40, 60, 100, 161, 218) , which have been pro-functional properties: self-renewal and the ability to generate multiple mature neural cell types. By contrast, pro-posed as a promising cellular source for the treatments of brain injuries and degenerative neurological diseases, genitors are proliferative cells with a limited capacity for self-renewal and are often unipotent (156, 179) . Previous such as stroke, spinal cord injury, Huntington's disease and Parkinson's disease (122, 137, 177) . Stem cell source, study led to the isolation of NSCs from the embryonic mammalian peripheral nervous system (PNS) (194) . low cell number, differentiation control, and in vivo tracking are still the challenges for clinical application CNS stem cells are usually identified on the basis of their behavior after isolation. They can not only produce of NSCs in neural diseases (229) . If NSC differentiations could be controlled, the embryonic and adult NSCs large clones containing neurons, glia, and more stem cells in adherent culture but also be cultured as floating could be good sources for cell transplantation. However, the processes by which NSCs emerge, and their regula-neurospheres (135, 160) . PNS neural crest stem cells grow as adherent clones containing peripheral neurons tion during development, are not clarified yet. During mammalian development, embryonic stem (ES) cells and glia, smooth muscle cells, and more stem cells (2). Markers that define NSCs in the CNS have been devel-arise from the inner cell mass (ICM) of blastocysts in the dividing embryo. They are capable of forming cells oped (22, 97, 203) . Increasing experiments have focused on overcoming of various tissues, which expand by cell division until final differentiation (13) . ES cells then acquire NSC the problems of: 1) how to obtain enough NSCs from reliable sources for autologous transplantation; 2) how identity with a default mechanism (188). NSCs are defined as cells that have the ability to self-renew and to to regulate neural plasticity of different adult stem cells;
3) how to control NSC differentiation in the adult ner-give rise to the three major cell types of the mammalian central nervous system (CNS): neurons, astrocytes, and vous system. Recently, two strategies have been pro- 134 HSU, LEE, AND CHIU posed in the cell therapy of CNS disorders: to transplant brain, has been elucidated. Recent data, using mouse ES cells (188) and human ES cells (206) , do seem to sup-exogenous NSCs into the brain injury sites and to stimulate the in vivo functional activity of endogenous NSCs port the default mechanism model (Fig. 1 ). Primitive NSCs (pNSCs) can be derived from ES cells. ES cells (110, 133) . The use of ES cell-derived NSCs for cell transplantation might also be another choice. In this re-are found to directly develop into pNSCs with a default process, which is independent of instructive factors, like view, we first summarize our current understandings of the ontogeny of NSCs and mechanisms of the neuronal fibroblast growth factors (FGF). The primitive NSCs exhibit characteristics, such as gene expression and differ-differentiation in adult neurogenesis. We then focus our attention on the regulation of other stem cell plasticity entiation potential, that are analogous to forebrain-derived NSCs. Therefore, in vivo there are two distinct sphere-and neurotrophic factors.
forming NSC populations that are present at different stages of development from embryonic day (E) 5.5-7.5
NEURAL STEM CELLS IN DEVELOPMENT
to adulthood (189). Pluripotent ES cells derived from the E3.5 ICM will commence a direct default transition The existence of multipotent cells found in the developing and adult CNS was shown in the early 1990s in the absence of inhibitory influences (e.g., TGF-β-related signaling) to yield leukemia inhibitory factor (LIF)- (185) . During mammalian CNS development, neurons are generated first from multipotent primitive NSCs dependent primitive NSCs, similar to those that can be isolated from the E5.5-7.5 epiblast. (pNSCs) during the embryonic period, followed by glia, the majority of which differentiate after most neurons LIF-dependent (but not FGF2-dependent) sphereforming cells are present in the earlier mouse embryo are born (136, 197) . Originally, NSCs were assumed to exist only in the embryonic region at the beginning of (82). The primitive NSCs can be passaged to give rise to definitive, FGF2-dependent NSCs, analogous to the neural tube formation (13) . A recent report indicated that there is one population of subventricular zone FGF2-dependent NSCs that can be isolated from the E8.5 neural plate (203) . FGF2-responsive definitive (SVZ) subependymal NSCs in the adult brain. However, the process by which NSCs emerge during embryonic NSCs first appear in E8.5 mouse embryos. The sequential expression of FGF2 and FGF1 within the developing and fetal development is not yet completely understood.
During development, neural cells arise from the ecto-forebrain neuroepithelium fits with the different functions played in NSC regulation (11) . Heparan sulphate dermal germ layer, which also produces epidermis. The classical model of this process, based largely on amphib-proteoglycans (HSPGs) represent low-affinity, highcapacity binging sites and are necessary for either FGF2 ian embryology studies, requires that nascent embryonic ectoderm receives a positive signal from a specialized or FGF1 to activate the appropriate tyrosine kinase receptors (148, 226) . For instance, FGF1, which binds group of dorsal mesodermal cells, termed the organizer, which instructs the adjacent ectodermal cells to adopt FGFR4 with high affinity, is more potent than FGF2, which does not bind FGFR4, to induce NGF synthesis a neural fate (74, 190, 215) . The validity of this theory, however, has been challenged by recent data. In the ab-and secretion by astrocytes (227). On the other hand, neurons, which bear all FGFRs, have been shown to be sence of the organizer, low-density cultures of dissociated ectodermal cells are able to differentiate into neural influenced by both FGF1 and FGF2 (181). Modifications of the composition of cell surface HSPG can regu-cells (70, 89, 174) . Signaling molecules secreted from the organizer tissue, such as noggin, chordin, and follistatin, late the sensitivity of neuronal cells to FGF1 and FGF2. During embryonic brain development, the definitive were found to exert potent neuralizing effects (79, 114, 173) , initially thought to represent the instructive neural-NSCs will generate neurons by asymmetric and symmetric divisions in a FGF2/FGF1-dependent manner. In the izing signal. However, it was found later that the neuralizing effects of these factors were dependent on inhibi-presence of FGF2/FGF1, this self-renewal passaging can be performed by symmetric cell divisions, which gener-tory interactions with bone morphogenic proteins (BMP), such that neurogenesis was proactively repressed (155, ate two daughter cells (FGF2/FGF1-dependent NSCs) with the same fate. The FGF2/FGF1 responsive def-173,231). These findings led to the development of the current more widely accepted model, the default model, initive NSCs can further be differentiated to produce neuronal and glial progenitors by asymmetric divisions. which states that each individual ectodermal cell has an intrinsic default program to become a neural cell (142).
Under the regulation of different neutrophic or differentiation factors, these NSC-derived neurospheres, neu-Thus, currently there exist two competing models of neural fate commitment. As of yet, there are few pub-ronal or glial progenitors can be differentiated to produce neurons, astrocytes, and oligodendrocytes (68,208) lished studies examining the neural default model in mammalian cells. However, the ontogeny of the NSCs, (Figs. 1 and 2). The research group of van der Kooy, using the FGF receptor kinase antagonist SU5402 and which can be isolated from embryonic and adult fore- The ontogeny and regulation of neural stem cells (NSCs) from embryonic stem (ES) cells. ES cells will become primitive NSCs (pNSCs) by a default mechanism. In the presence of leukemia inhibitory factor (LIF), the pNSCs are maintained in undifferentiated and proliferative state and give rise to FGF2/FGF1-dependent definitive NSCs (dNSCs). In the presence of FGF2 and FGF1, the dNSCs can self-renew repeatedly and generate neural progenitors, which are responsive to differentiation factors. The dNSCs are presented as a hierarchy beginning with the multipotent stem cells and progressing to the terminally differentiated neuronal and glial cell lineages. Differentiation along the glial lineage may be a default state of development reflected in the progression of NSCs along the neuronal progenitor → glial progenitor → astrocyte lineage. The restrictions of fate at several steps require the signaling of FGF2/FGF1, followed by withdrawal of FGF and the presence of other growth factors, including brainderived neurotrophic factor (BDNF), glial-cell-line-derived neurotrophic factor (GDNF), or platelet-derived growth factor (PDGF). The question mark (?) means other undefined factors. Glial progenitors can be further differentiated into astrocyte and oligodendrocytes by LIF, ciliary neurotrophic factor (CNTF), and triiodothyronine (T3). Neuronal progenitors can be further differentiated into neurons by platelet-derived growth factor (PDGF) or other factors. FGFR1 −/− ES cells, recently demonstrated that FGF sig-gous for a mutated FGFR1 allele die early in development and show abnormal growth and aberrant mesoder-naling is not required for ES cell default neuralization, but is crucial for ES-derived primitive NSC proliferation mal patterning (43) . Another group disrupted the FGFR2 gene, and found that FGFR2 seems to contribute to the (188). outgrowth, differentiation, and maintenance of the inner FGFR ad HSPGs in Neural Cells cell mass (3). FGFR3 plays a role later in development by negatively regulating osteogenesis (42) . Different ex-The FGFR family consists of four closely related members (FGFR1-4). Their extracellular part has two pressions of FGFR mRNAs in the cultures of neurons, astrocytes, and microglia are observed regardless of the to three immunoglobulin-like domains that bind FGFs. Heparin-binding sequence, located between immuno-age of the embryos and time in culture. Neurons express high levels of all four members of the FGFR family globulin domains, is followed by single pass transmembrane domain and intracellular tyrosine kinase domain.
while astrocytes express mainly FGFR4, and lower levels of FGFR1, FGFR2, and FGFR3 mRNAs are only Deng et al. demonstrated that mouse embryos homozy- Figure 2 . Neural stem cell-derived neurospheres give rise to neuron, astrocyte, and oligodendrocyte cell lineages under differentiation conditions. The definitive NSCs will proliferate in an FGF2/FGF1-dependent manner to generate neurospheres. The neurospheres are an aggregate of NSCs and neural progenitor cells. In the presence of FGF2 and FGF1, this self-renewal can be passaged indefinitely. Under differentiation conditions, the NSCs can be differentiated to produce neurons, astrocytes, and oligodendrocytes. When induced to differentiate, neurospheres generate glial fibrillary acidic protein (GFAP)-positive astrocytes, galactosylceramidase (GalC)-positive oligodendrocytes, and neurons that are positive for βIII-tubulin and microtubule-associated protein 2 (MAP2). In the immunostaining, primary antibodies used included anti-GFAP, anti-GalC, anti-βIII-tubulin, and anti-MAP2 antibodies. Cell nuclei were counterstained with the nuclear dye 4′,6-diamidino-2-phenylindole (DAPI). Scale bar: 100 µM.
barely detectable in astrocytes. In contrast, when com-play a key role in orchestrating the formation and stabilization the FGF-FGFR complexes. To date, the interac-pared to neurons, microglia express mainly FGFR3 and lower levels of all the other FGFR mRNAs. Immunocy-tions of HSPGs with FGF2 have been investigated more than with FGF1. Three major cell surface-associated tochemical localization of FGFR1 gene product shows association with the plasma membrane of all neurons.
HSPGs, glypicans, sydecans, and perlecan, have been identified in the formation of FGF-FGFR complex and Labeling could be observed at the level of cell bodies, some processes, and the axon hillock. In astrocytic cul-regulation of neural development (228) . Wu and Lech recently suggested the nonreducing end of HS is not tures, GFAP-positive astrocytes showed weak labeling on the cell surface, whereas in microglial cultures only trimmed by heparanase and is capable of supporting fibroblast growth factor signaling complex formation ameboid cell membranes were strongly stained; flat, adherent ramified cells showed a much weaker labeling (224) . HSs from different tissues and cell types vary in their O-sulfation. Variation in the pattern of sulfation (66) . All four members of the FGFR family are expressed by human fetal neurons. The presence of mRNA allows specific interactions with FGF1, FGF2, and FGF4 (72) . Differences in the distribution of basic for FGFR1, FGFR2, FGFR3, and, in very low amounts, for FGFR4 has been previously reported in human fetal amino acids upon the surface of the FGF1 and FGF2 lead to markedly different heparin-binding properties brain extract (4), but the cellular source of each specific mRNA is not identified. (159) . FGF2 will bind to heparin/HS pentasaccharides that are devoid of 6-O-sulfate groups as long as they It has been suggested that HSPGs are present both on the cell surface and in the extracellular matrix. FGFs contain one or more critically positioned N-and 2-Osulfates (128) . In contrast, FGF1 binding to heparin/HS bind not only to their cognate FGFRs but also to specific HSPGs. The heparan sulphate (HS) chains of HSPG oligosaccharides is thought to require N-, 2-O-, and 6-O-sulfation (107) . Interestingly, perlecan seems to nega-Neurogenesis in the adult brain relies on NSCs, which exist not only in the embryonic nervous system tively regulate FGF1-FGFR3 signaling, possibly by sequestering and inactivating FGF1, via the HS chains but also in the adult nervous system of all mammalian organisms (60) . After the discovery of NSCs in the em-(164).
Steinfeld et al. demonstrated that syndecan-2 and bryo, adult NSCs have also been found in the principal adult brain neurogenic region, in the SVZ of the lateral glypican-1 stimulate FGF2-FGFR1 interaction and signaling in K562 cells (193) . They suggested that the form ventricle (106, 126) . Genesis of neurons has also been reported in the primate prefrontal cortex, temporal cor-of HSPG that activates FGF2 signaling might be a heparanase-generated product. Some HSPGs, such as glyp-tex, and parietal cortex (1,65,96), and it has been proposed that the SVZ might be the source of these neurons ican-1, glypican-4, perlecan, sydecan-1,2, and heparinbinding growth-associated molecule (HB-GAM), have
(1,96). NSCs located in the SVZ of the lateral ventricle proliferate and give rise to neuroblasts, which then mi-been substantiated for their important roles in FGF2 signaling (225) . Hagihara et al. demonstrated that glypican-grate in the rostral migratory stream (RMS) through mature neural tissue. The subgranular zone generates the 4 expression is not only in the embryonic mouse brain but also in sites of neuronal regeneration in the postnatal granule cells of the hippocampus (93, 94) , whereas the SVZ is the source of new olfactory bulb neurons (124). brain (73) . In addition, they also found that glypican-4 synthesized in cultured neural precursors specifically Some of the new neurons reach the olfactory bulb and migrate in the olfactory bulb to their final destination. At binds FGF2 through its HS chains. Glypican-4 is also highly expressed in ventricular zone and adult dentate this stage, they already display dendritic spines, which suggests that they are receiving synaptic inputs. How-gyrus (DG) of the developing brain. Ford-Perriss et al. indicated that sydecan-1 and glypican-4 are the most ever, their spiking activity does not occur until late into the maturation process (23) . This delayed maturation of highly expressed in the developing brain. They also demonstrated that FGF2-dependent neural precursor cell excitability may prevent the newborn cells from disrupting the function of the adult preexisting circuitry. Sea-growth is blocked by sodium chlorate, an inhibitor of HS synthesis, and rescued by the addition of exogenous berg and van der Kooy (178) indicated that the adult hippocampal DG contains only neural progenitors that HS (54) . Furthermore, Leadbeater et al. (117) examined the intracellular dynamics of FGF2, FGFR1, and the do not self-renew and generate only glial lineage. These DG-derived cells do not exhibit the fundamental stem HSPGs syndecan-2 and -3, glypican-1 and -2, and perlecan in neurons and glia in and around adult rat cerebral cell properties of self-renewal and multipotentiality. Their suggestion was that there is only one population wounds. They suggested that the dynamics of FGF2-FGFR1-HSPG complex formation is a key role for indi-of SVZ subependymal NSCs in the adult brain, although the subependymal NSCs and subgraular progenitors vidual HSPGs in regulating FGF2 storage, nuclear trafficking, and cell-specific injury responses in CNS have a common anatomical origin during development.
In adult hippocampal neurogenesis, neural progeni-wounds. On the other hand, Hienola et al. suggested a key role of HB-GAM in NSC proliferation, differentia-tors located in the subgranular zone proliferate and give rise to immature neurons. Many of these newly gener-tion, and migration (81) . Briefly, they demonstrated that exogenous added HB-GAM inhibits FGF2-dependent ated cells die between the first and second week after they are born. The surviving neurons then migrate into neurosphere formation and FGF receptor phosphorylation in FGF2-stimulated NSCs. Furthermore, endoge-the molecular layer (99) . Within 4 weeks, they send axons to the CA3 region to form mossy fibers and project nous disruption of HB-GAM gene results in an increased neuronal differentiation.
dendrites to the outer molecular layer (76, 132, 182, 207) . During this period, the newly generated neurons become NEURAL STEM CELLS IN ADULT BRAIN electrically active. The complexity and density of their dendritic spines, however, continue to grow for at least Adult neurogenesis was first detected in regions of mammalian brain in the 1960s. However, the generation several months. Thus, the course of neuronal development for granule neurons born in the adult brain appears of new neurons throughout adulthood and their origins were not revealed until 1980s-1990s (51,185). The func-much more protracted than for those generated during embryonic stages (91) . tion of adult brain neurogenesis is not completely understood. The hypothesis is that, in the adult hippocampus, PLASTICITY OF ADULT STEM CELLS neurogenesis is involved in learning and memory (99) . Moreover, some correlative evidence has been accumu-Stem cell plasticity is the ability of cells to exhibit mature phenotypes that are different from their original lated suggesting that neurogenesis in these brain areas compensates for dying neurons (98) and is necessary for tissue. The major function of stem cells in adult tissue is to repair or regenerate the damage tissue (69) . Neural the functional integrity of these structures (17) .
transplantation programs have historically depended on ments like 3-isobutyl-1-methylxanthine or cAMP, which could increase the intracellular concentration of cAMP; the use of fetal neural tissue-derived cells or immortalized neural cell line. However, these projects finally but no mature neural marker, such as neurofilament M (NF-M), MAP2, Tau, and S-100, could be detected in reach obvious limitations, such as tissue availability, cell stability, and ethical challenge.
long-term culture (18, 44, 170, 222) . The cAMP, as a neural inducer, was also observed in human prostatic adeno-Recently, exploitation of an alternative source of NSCs from adult stem cells is an important issue. Adult carcinoma cells by Bang et al. (8) . Interestingly, this phenomenon is reversible; removing these reagents re-stem cells have been identified from peripheral blood (111) , bone marrow (69), adipose tissue (71, 165) , scalp sults in rapid loss of the neural phenotype and marker expression (38) . Some studies focus on combinations of (183), cord blood (151, 214) , and umbilical cord (127, 140, 212, 216) in neonatal tissue. These cells exhibit dif-cytokines, different substrates, and extracellular matrix components for neural induction of MSCs to evaluate ferent potentiality of neuronal progenitor/precursor cell differentiation under optimal neurotrophic factors and the ratio of differentiation. Under these culture conditions, MSCs are toward neural phenotypes including chemical compound treatments.
neuronal lineage marker expression in evaluated per-Does Blood Become Brain?
centage than before (88, 102, 157) . In contrast to morphological neuronal features and marker expressions of neu-Cord blood mononucleated cells (MNCs) have recently been regarded as a new source for cell therapy.
ronal differentiation, the electrophysiological function tests, such as resting membrane potentials, membrane The subpopulation of CD133-positive hematopoietic stem cells (HSCs) could present neuron-specific markers un-permeability to potassium and sodium, and actions potential are considered as essential evidences of true neu-der retinoic acid treatment (6, 87) . Besides the CD34positive cells, several studies have also explored the ral transdifferentiation of MSCs. Another group directly injected human MSCs into the rat brain striatum with CD34-negative mesenchymal-like cells isolated from cord blood. When exposed in FGF2 and EGF, these cells the purpose of testing survival, integration, and differentiation. The MSCs exhibited similar characteristics to could be differentiated to TuJ1 and GFAP-positive cells. In animal transplant experiments, these human cells that of implanted NSCs and expressed GFAP, suggesting that some of the injected MSCs differentiate into a were detected in SVZ, cortex, and corpus callosum with anti-human nuclei and either TuJ1 or GFAP antibody neuronal phenotype in vivo (5) .
For another cell population in bone marrow, HSCs, (50, 63, 230) .
Another population of MNCs in human circulating many studies examine the neural differentiation of HSCs by transplantation. Eglitis et al., in 1997, claimed that blood detected positive for CD14, CD45, CD34, and type-I collagen had been reported as monocyte-derived HSCs can be found in the CNS as microglia and astrocytes (GFAP-positive) after intravenous transplantation multipotential cells (MOMC) based on their potentiality to differentiate into mesodermal and neuroectodermal (47) . But a similar result could not be repeated with single cell HSC transplantation (209). Castro et al. also lineages. Kodama et al. recently demonstrated that the MOMC can be cocultivated with rat neurons in vitro, failed to detected any β-gal-positive cells in brains or cervical spinal cords of irradiated mice that received and the neuronal marker expression is stronger and CD14/CD45 is weaker (104) . It would be important to HSCs or MSCs from ROSA-26 mice with a lacZ-containing transgene (25). Collectively, these data suggest that reproduce these observations in animal transplantation studies.
bone marrow stem cell propensity in transdifferentiation to neural lineages may depend on the experimental sys-Bone Marrow Stem Cells tems, including cell population, manipulation, and detection techniques (138, 199) .
Mononucleated cells collected from bone marrow could be divided into two populations: hematopoietic
Processed Lipoaspirates Have stem cells and nonhematopoietic (mesenchymal) stem
Neuroprogenitor Potency cells (MSCs), which could be induced and differentiate to bone, cartilage, fat, muscle, and neuron (69) . Both of The clinical and research use of bone marrow MSCs has some problems, including pain, morbidity, and low them could be harvested and expanded with different culture conditions, and verified with different cell sur-stem cell number. Adipose tissue, like bone marrow, is derived from mesenchymal and is easier to process in face profile by fluorescence activated cell sorting (FACS).
A large body of studies has focused on neural trans-the clinical setting than bone marrow. These adiposederived adult stem cells (ADAS) share similar cell sur-differentiation of MSCs. Briefly, culture substrates in neural differentiation condition are critical. MSCs could face marker profiles and specific differentiation potential with bone marrow-derived MSCs (232). become early neural progenitors under optimal treat-In addition, human adipose tissue and rhesus and for Parkinson' disease. In addition, UMSCs could survive in xenotransplantation and did not stimulate im-mouse adipose tissue also could be a source for stem cells (56, 92, 150) . Under optimal treatment, the clongenic mune rejection (24,217). Therefore, UMSCs also provide another choice for cell replacement therapy in ADAS exhibit multiple potentialities and not solely a mixed population of unipotent progenitor cells (71) . The neurogenic disorders. The induction medium components, extracellular ma-neuronal differentiation protocols of ADAS are similar to bone marrow MSCs. The undifferentiated ADAS ex-trix, and specimen quality are reported to determine the in vitro neuronal trandifferentiation efficiency of the hibit a low level of nestin and GFAP expression like NSCs. After induction, ADAS show neurosphere forma-adult stem cells from bone marrow, adipose, scalp, foreskin, umbilical cord, and cord blood. Although the ex-tion, neuron-like morphology, and increased expression of three neuron-specific proteins: NSE, MAP2, and pressions of neuron-specific markers confirmed by immunofluoresence staining or RT-PCR are acceptable as NeuN (93) . In the literature, neuronal differentiation of ADAS does not exhibit electrophysiological functions neuronal differentiation evidence, the electrophysiological function tests cannot be ignored. In vivo transplanta- (105) . Although in vitro neuronal transdifferentiation is not easy to prove, in vivo transplantation experiment tion data reveal that adult stem cell will migrate to an optimal region after injection and express neuronal does suggest that ADAS could improve neurological function in ischemic rat brain without any immunosup-markers; these phenomena are yet to be clarified. pression. Potentially, adipose tissue may provide a use-NEUROTROPHIC AND ful autoplastic therapy for human neurological degenera-DIFFERENTIATION FACTORS tion disorders and stroke (93) .
Identification of external signals involved in the regu-Scalp and Other Tissue Stem Cells lation of NSC proliferation and differentiation may allow for improved transplantation methods and augment the Recently, more publications suggest that adult stem cells not only exist in bone marrow or adipose tissue but treatment of neurodegenerative disorders. Here, several important neurotrophic factors and differentiation fac-also in scalp tissue. Scalp tissue provides another source of neurogenic adult stem cells. Shih et al., in 2005, dem-tors, such as LIF, FGF1/FGF2, PDGF, NGF/BDNF/NT-3, GDNF, and retinoic acid (RA) in mammalian neural onstrated that clongenic human neurogenic mesenchymal stem cells (c-hSCPs) were isolated from the scalp. development are discussed. The undifferentiated c-hSCPs exhibit early progenitor Leukemia Inhibitory Factor (LIF) marker SOX2 and neurogenic marker GFAP and NCAM. According to different induction protocols, c-hSCPs can LIF, the first soluble factor identified as having potential to maintain the pluripotency of mouse ES cells transdifferentiate to neuronal or astrocytic lineage precursors, and this is verified by gene expression. Further- (149) , is a member of the family of interleukin-6 (IL-6) type cytokines, which have overlapping, pleiotropic more, they did not perform the electrophysiological function tests in the study, but showed the in vitro neu-effects on a variety of different cell types and activate target genes involved in survival, apoptosis, prolifera-ronal differentiation efficiency of c-hSCPs is better than bone marrow MSCs (183) . Scalp tissue is easier to ob-tion, and differentiation, as well as suppression of differentiation (78, 108) . tain than bone marrow and adipose tissue in specimen collection and manipulation. Besides human scalp tis-
The effect of LIF is mediated through a cell surface complex composed of LIFRβ and gp130. LIF binds di-sue, neonatal human foreskin tissue are also regarded as the sources of neurogenic mesenchymal stem cells rectly to the low-affinity LIF receptor β (LIFRβ) that heterodimerizes with glycoprotein 130 (gp130) (108). (200).
Umbilical cord, in addition to cord blood, is another The formation of a high-affinity trimeric complex composed of the two class I cytokine receptors, LIFRβ/ new source of adult stem cells in recent publications. The mesenchymal stem cells exist in Wharton's Jelly of gp130, and LIF, leads to the activation of at least two downstream pathways essential for regulating biological human umbilical cord (HUMSCs). They exhibit similar cell surface marker profile and differentiation potential responses in ES cells: the JAK-STAT and the MAPK pathway. It was shown that LIFRβ is not sufficient to with bone marrow MSCs (55,212). The HUMSCs could be differentiated into dopamine-secreting neuron cells in mediate the signal to maintain ES cells' self-renewal, whereas gp130 is (147, 192) . This suggests that gp130 vitro. In Parkinson's animal transplantation, HUMSCs were shown to migrate to the striatum of bregma and serves as the main component of the activated LIFRβ-gp130 receptor complex. This is in line with other re-partially correct amphetamine-evoked rotational behavior without immunosuppression; this indicates HUMSCs ports that homodimerization of the LIFRβ cytoplasmic domain results in diminished activation of downstream may have the potential for development of cell therapy pathways compared with LIFRβ/gp130 heterodimeriza -152,211) . In PNS cultures, FGF1 has been shown to promote neuronal regeneration (37) and survival (204). tion or gp130 homodimerization (192) . Signaling through the LIFRβ/gp130 receptor complex is negatively regu-Within the CNS, FGF1 has been shown to stimulate glial mitogenesis (16, 41) and to have trophic effects (125). lated by members of a recently characterized family of proteins known as the suppressors of cytokine signaling,
The trophic effects of FGF1 also have been demonstrated in primary neuronal cultures and in neuronal cell or SOCS, in particular SOCS3. Emery et al. (49) suggested that SOCS3 negatively regulates LIF signaling in lines (64, 134, 163, 167) . Furthermore, FGF1 has been shown to promote mitogenesis in neuroblasts (223) , to neural precursor cells. They demonstrated that SOCS3 −/− cultures of embryonic neural precursor cells display en-enhance both neurite initiation and elongation in retinal ganglion cells (123) , and to stimulate neuronal differen-hanced self-renewal capacity while maintaining their multipotential capacity. They suggested that SOCS3 tiation and neurite outgrowth in PC12 cells (168) . FGF1 also has been found to be released into the wound cavity subserves an important role in completing a negative feedback loop in LIF signaling in neural precursor cells following brain lesions (146) . The human FGF1 gene is over 100 kb long and con-and there was a temporal association between the induction of SOCS3 and the downregulation of LIF-mediated tains three protein-coding exons and a long 3′ untranslated region. It also contains at least four upstream un-STAT3 phosphorylation.
Koblar et al. indicated that neural precursor differen-translated exons, designated 1A, 1B, 1C, and 1D, which are alternatively spliced to the first protein-coding exon tiation into astrocytes requires signaling through the LIF receptor (103). Holmberg and Patterson (84) used LIF (145, 153) . The different transcripts code for the same single chain polypeptide with a molecular mass of 17.3 knock-out (KO) mice to test if LIF regulates astrocyte, microglial, and neuropeptide responses to a mild insult.
kDa. The expressions of the four mRNAs generated by alternative splicing are regulated in a tissue-specific Compared to wild-type mice, the LIF KO mouse displays reduced astrocyte and microglial activation in the manner and rely on the use of different promoters (143, 145) . Thus, FGF1A transcript predominates in the hippocampus. In addition, LIF KO mice display dramatically altered neuropeptide Y (NPY), but not galanin, human kidney (145) , and FGF1C and 1D transcripts predominate in vascular smooth muscle cells and fibro-expression in response to injury. Therefore, they suggested that LIF is also a key regulator of astrocytic, blasts (33) . Within the human brain (145) and retina (144) , the FGF1B transcript predominates. Both FGF1 microglial, and neuronal responses in a low-dose pilocarpine injury model. Although Wnt is considered as a mRNA and its protein have been anatomically localized within the CNS of adult rodents (48, 53, 112, 195, 220) . LIF-like factor in ES cells, Ogawa et al. (149) recently suggested that Wnt is not sufficient but has a synergistic FGF1B mRNA was expressed in phylogenetically older brain regions, which are involved primarily in process-effect with LIF in maintaining pluripotency of mouse ES cells.
ing information from exteroceptive sensory mechanoreceptors and in motor control. The presence of FGF1 in Fibroblast Growth Factor 1 and 2 (FGF1/FGF2) the adult brain suggests a role for FGF1 in neural maintenance in addition to in neurogenesis. Through the FGF proteins are small peptides of 155 to 268 amino acid residues (77, 186) . The degree of sequence identity characterization of F1B-Tag transgenic mice, which contain the T antigen fused downstream of the FGF1 between different family members is 30-60% in a "central domain" of ϳ120 amino acids. Most FGFs are con-promoter 1B, it appears that the 1B promoter is active in NSCs of the SVZ near tegmental region (32) . stitutively secreted using the endoplasmic reticulum-Golgi secretory pathway (45) . A small subgroup of FGF FGF2, also known as basic fibroblast growth factor, is one of the most potent mitogens and survival factors proteins, such as FGF1, 2, 9, 16, and 20, lacks the NH 2terminal signal sequence but is still transported in the for NSCs culture (58, 161, 162, 202, 218) . FGF2 has been used both alone and in combination to isolate and main-extracellular space. A third subgroup of FGF proteins, FGF11 to FGF14, lacks the signal peptide and remains tain NSCs of the adult SVZ and the spinal cord in culture (141, 184) . FGF2 alone is sufficient to maintain neu-intracellular. In the literature, the roles of FGF1 and FGF2 and their interactions with FGF receptors and ral stem cells from either the adult striatum (67) or hippocampus (58) of rodents. Taupin et al. (196) have HSPGs in mammalian neural development have attracted much attention and will be discussed here.
shown that cystatin C, a cystein proteinase inhibitor, is able to potentiate the mitogenic activity of FGF2 and FGF1, also known as acidic fibroblast growth factor (213) , is expressed predominantly in neural tissues, in-enables expansion of rat hippocampal NSCs from single cells. Recent studies using FGF2-responsive hippocam-cluding brain and retina (12, 45, 213) ; it presents its effect through high-affinity cell surface receptors, which are pal neural progenitors show that these cells can differentiate into cells with phenotypes of GABAergic, dopa-distributed densely throughout the nervous system (80, minergic, and cholinergic neurons when exposed to both al. (52) detected PDGF α-receptor expression already on dissociated cortices at E15. In contrast, the β-receptors retinoic acid and neurotrophins (197) . In addition, forced expression of the orphan nuclear receptor Nurr1 (115) were hardly detected in uncommitted cells, suggesting that in cortical stem cells the α-receptor is the predomi-in these cells induces predominant differentiation of tyrosine hydroxylase-positive dopaminergic neurons (116, nant receptor isoform. Tyrosine phosphorylation of the PDGF α-receptor is 169). NSCs expanded in the presence of FGF2 retain pluripotency and integrate into the host tissue where not seen in dissociated cortices (221) , and during differentiation, induced by discontinued addition of FGF2, they respond to local differentiation signals. Wagner et al. (210) have shown that subcutaneous injection of PDGF α-receptor phosphorylation is not detected by using phosphotyrosine antibodies (52) . The cortical stem FGF2 increases the number of proliferating cells in the SVZ and olfactory tract. Injection of FGF2 in the lateral cells responded to addition of PDGF-AA by receptor phosphorylation, such that a prolonged exposure to the ventricle of an adult rat brain expands the SVZ NSC pool and increases the number of neurons in the olfac-ligand gives rise to sustained receptor activation.
In contrast to the PDGF α-receptor, Erlandsson et al. tory bulb. Martens et al. (133) also suggested in vivo infusions of FGF2 into lateral ventricle will generate reported that the β-receptor is barely detectable during the first days of differentiation in cortical stem cells, and some new neurons, but the fourth ventricle of the spinal cord in adult mouse brain in response to FGF2 only pro-no phosphorylation on tyrosine residues in response to PDGF-AA (52) . Therefore, the increased BrdU uptake duces new astrocytes and oligodendrocytes. Furthermore, combined injection of FGF2 and cystatin C to the and total cell number after PDGF-AA stimulation are mediated through PDGF α-receptors. Phosphorylation adult DG stimulates proliferation and neurogenesis in the adult rat hippocampus (197) .
of the PDGF β-receptor is also seen when cortical stem cells differentiated in the absence of PDGF-AA (52).
Platelet-Derived Growth Factor (PDGF)
PDGF β-receptor is expressed in neurons in many areas of the CNS (205), and Smits et al. reported that PDGF-PDGF is reported not only to enhance neuronal differentiation but also support the long-term survival of BB exerts neurotrophic activity on neurons from newborn rats' brain (187) . PDGF-BB not only directs neuronal dif-differentiating NSCs (221) . Hutchins and Jefferson (85) detected PDGF-A-positive cells throughout the ventricu-ferentiation, but also supports long-term survival of the differentiating neural stem cell and prevents apoptosis. lar zone at mouse E11.5, which is 2 days after neural tube closure and before the differentiation of most glial PDGF-BB and the β-receptor are also involved in survival and proliferation of neurons (61) . Both c-Myc cells in all areas of the nervous system. Some PDGF-Breactive cells can also be found in the SVZ of E14 rat and c-Fos are core transcription factors activated by PDGF in many cell types. PDGF-AA-stimulated c-fos embryos, which is when rapid cellular proliferation and migration occur (172) .
RNA expression in cortical stem cells peaked at 1 h, suggesting that it is mediated by signaling through PDGF signaling is reported to function during glial cell development by maintaining glial precursors in an PDGF α-receptors. The possibility that c-fos activation is a secondary phenomenon is less likely, because of the undifferentiated and proliferating state. By forcing the overexpression of PDGF, Dai et al. (39) have observed time frame of induction (52) . an autocrine signaling loop in cells that also express the Nerve Growth Factor (NGF)/Brain-Derived PDGF receptor and indicated that PDGF autocrine stim-Neurotrophic Factor (BDNF)/Neutrophin-3 (NT-3) ulation can dedifferentiate GFAP-expressing astrocytes to glial progenitor-like cells. This process can be re-NGF, BDNF, and NT-3 are members of neutrophin family (46) ; they play a role in preventing neural death versed by blocking the PDGF receptor kinase, indicating that these PDGF-driven cells continue to depend on sig-and in favoring the recovery process, neural regeneration, and remyelination. NGF is the first neurotrophic naling through the PDGF receptor in culture, and have not genetically evolved to be independent of these sig-factor demonstrated to be required for normal neuronal development. Anti-NGF antibodies injected into new-naling pathways (52) .
PDGF was the first growth factor cloned (31); it is born rodents specifically destroy the peripheral sympathetic nervous system (34) , while prenatal exposure to active either as a homodimer (AA, BB) or heterodimer (AB). Activation of PDGF receptors is brought about by NGF antibodies also causes the death of sensory neurons of spinal ganglia (90) . Subsequently, BDNF is isolated ligand binding to dimerizing receptor subunits α or β. The BB homodimer can only bind to β-receptor sub-(9,10) and cloned (119) , revealing that the amino acid sequence of BDNF was about 40% identical to that of units, whereas PDGF-AA can activate both αand βreceptors (219). The AA homodimer, however, has a NGF. Additionally, NT-3 is also identified as the NGFlike neurotrophic factor (83, 130, 166) . slightly lower affinity for the β-receptor. Erlandsson et Regulation of neurotrophin receptors during cerebel-aminobutyric-containing and serotonergic neurons (120). GDNF is shown to maintain several neuronal popula-lar development is important for the timing and morphology of axonal growth (180). Responsiveness of neu-tions in the CNS, including midbrain dopamine neurons and motoneurons (171) . GDNF protects midbrain dopa-rons to a given neurotrophin is governed by the expression of two classes of cell surface receptors. For NGF, these minergic neurons from 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity (201) and axotomy-are p75NTR (p75) and p140trk (trkA) receptor tyrosine kinases. The related trkB receptor tyrosine kinase binds induced degeneration (15) . GDNF promotes the survival of two populations of CNS neurons: motoneurons and BDNF and the trkC receptor binds only NT-3, while p75 is able to interact with each neurotrophin with equal midbrain dopaminergic neurons. Buj-Bello et al. showed that GDNF promotes the survival of sympathetic, para-affinity, though with different rate constants. After ligand binding, the neurotrophin-receptor complex is sympathetic, proprioceptive, enteroceptive, and small and large cutaneous sensory neurons, whereas sympa-then internalized and transported in the axon to the soma. Both receptors undergo ligand-induced dimeriza-thetic, parasympathetic, and proprioceptive neurons become less responsive to GDNF with age, and enterocep-tion, which activates multiple signal transduction pathways. These include the ras-dependent pathway utilized tive and cutaneous sensory neurons become more responsive. GDNF mRNA is expressed in the tissues in-by trk to mediate neurotrophin effects such as survival and differentiation, while p75 activates less well under-nervated by these neurons and developmental changes in its expression in several tissues mirror the changing stood pathways and can modulate trk activity (29, 158) .
BDNF is implicated in maintaining basal levels of responses of the innervating neurons to GDNF (19) . These results show that GDNF promotes the survival of hippocampal neurogenesis (118) , stimulates neurogenesis (176) , is upregulated in the dentate gyrus in re-multiple PNS and CNS neurons and suggest that GDNF may be important for regulating the survival of various sponse to neurogenic stimulating exercise (52) , and has a role in mediating the effect of antidepressant drugs on populations of neurons at different stages of their development (46) . hippocampal neurogenesis (168) . Bull and Bartlett found that BDNF is essential for the production of neurons Retinoic Acid (RA) from the hippocampal progenitor cells, being required during proliferation to trigger neuronal fate (20) . They Retinoids, which include vitamin A (retinol) and its derivatives, are critical contributors to the proper devel-also observed that BDNF is critical for hippocampal neurogenesis. Only when BDNF was included in the opment of the vertebrate CNS (129) . They also regulate multiple functions in the adult including vision, cellular growth medium during neurosphere proliferation were neurons produced by hippocampal progenitors. When differentiation, immunity, fertility, and the homeostasis of several tissues. Thus, during both early phases of de-hippocampal progenitors were grown in the presence of mitogens alone, only glia were generated (20) . velopment and continuing through adulthood, retinoids are vital for normal physiology. NT-3 plays an essential role in the development of both the neural crest-derived PNS and the CNS (27) . In
The biological effects of retinoids are mediated by retinoid receptors, members of the nuclear receptor su-the developing cerebellum, neonatal granule neurons in the external germinal layer respond preferentially to perfamily. Nuclear receptors are ligand-induced transcription factors that respond to a variety of lipophilic BDNF, while mature neurons within the inner portion of the cerebellum respond preferentially to NT-3. Segal steroids, hormones, and fatty acids (14, 129) . Retinoid receptors consist of the retinoic acid (RA) receptors et al. have shown that anatomic distinction reflects a developmentally regulated switch at the level of neuro-(RARα, β, and γ), which bind both all-trans RA and 9cis RA (62,154), and the retinoid X receptors (RXRα, trophin receptor gene expression (180). Chalazonitis also demonstrated that NT-3 acts directly on the precur-β, and γ), which bind 9-cis RA. RARs and RXRs form heterodimers and bind DNA at specific sequences to sor cells and that it also acts in combination with GDNF to promote the survival and differentiation of enteric promote transcription of their target genes. RAR, RXR, and RA activity occur in distinct patterns neurons and glia (28).
in the mature CNS including the DG, a hippocampal Glial Cell Line-Derived Neurotrophic Factor (GDNF) region distinguished as being one of the few sites of ongoing proliferation and neuronal development in the GDNF is a potent survival factor for midbrain dopaminergic neurons (120). In embryonic midbrain cultures, adult CNS (21, 36, 93, 95, 109, 139, 210) . RA is necessary for long-term synaptic plasticity between neurons in the recombinant human GDNF promotes the survival and morphological differentiation of dopaminergic neurons.
hippocampal Schaffer Collateral pathway (30) , but the localized and intense concentration of RA and expres-GDNF does not increase total neuron or astrocyte numbers nor did it increase transmitter uptake by gamma-sion of RAR and RXR in the adult DG suggests that retinoids could also contribute to the region-specific obtained from ES cells through sorting could bypass this tumorigenic propensity (57). Thus, therapeutic application phenomenon of neurogenesis.
Embryonic neurogenesis is closely regulated by RA using human NSCs in the treatment of CNS diseases should be expected to advance the field significantly. at various time points and regions. For example, RA signaling controls the number, timing, and subtype pro-Even though increasing evidences indicate that using exogenous NSC transplantation might recover the func-duced during motor neuronal differentiation in the spinal cord (189). Although neurogenesis primarily occurs dur-tion of the injured CNS in vivo, this clinical application is still limited by the poor understanding of controlling ing embryogenesis and early development, it persists in restricted regions in the mature CNS. These areas of the differentiation and behavior of NSCs in situ. Environmental factors, such as the extracellular neutrophic proliferation occur in the SVZ of the lateral ventricle and the subgranular zone of the hippocampal DG. In the factors and stem cell niches, will determine the NSC cell fate. Increasing data suggest that the choice of using ei-subgranular zone, cells divide, migrate into the granular cell layer, and differentiate into neuron or glial cells ther neural progenitors or multipotent NSCs for cell transplantation should depend on the diseased target (59, 60) .
Haskell and LaMantia (75) used a RA reporter trans-(121,229). In addition, cord blood, bone marrow, PLA, or scalp may also be the source of neural progenitors. gene (7, 35, 113, 129) and several independent markers to identify SVZ cells that respond to endogenous RA. Fur-More efforts are needed to completely elucidate the mechanisms that regulate the differentiation of NSCs thermore, they suggested that endogenous RA, via distinct metabolic and transcriptional pathways, regulates and neural progenitors in different stem cell niches. The mobilization of endogenous NSCs is regarded as cell proliferation in a subset of slowly dividing astrocytes in the adult SVZ, as well as a subset of prolifera-another strategy for repair of CNS diseases. The research group of van der Kooy demonstrated that endoge-tive radial glia in a comparable region of the developing forebrain.
nous stem cells and progenitors around the fourth ventricle and central canal of the spinal cord proliferate in Jacobs et al. (86) recently demonstrated that RA depletion does not influence proliferation within the sub-response to exogenously applied growth factors, but, unlike in the lateral ventricle where they generate some granular zone, but rather inhibits neuronal differentiation in RA-deficient mice. The need for RA occurs in the new neurons, they only produce new astrocytes and oligodendrocytes (133) . Thus, pharmacological manipula-early differentiation process because the expression of the immature neuronal marker doublecortin (dcx) is dra-tion of endogenous NSCs could be a useful approach for cell replacement therapies. Alternatively, neurotrophic matically decreased in RA-deficient mice. Although the rate of proliferation is normal, the survival ability of factors such as FGF, NGF, and PDGF delivered through packing by nanomaterials could become useful in the newborn cells in the DG is lowered in the absence of RA. Using a highly specified population of adult-derived therapeutic regimens. It is also envisioned that engineering of NSCs that overproduce certain neurotrophic fac-NSCs, they identified a set of RA-responsive genes including lipid modulator proteins (such as SREBP1, tors before transplanting into patients may benefit from the prowess of both NSCs and neurotrophic factors in CD36, and ABCA1) and components of the Wnt signaling pathway, suggesting that cell signaling and lipid mo-clinical situations. This article suggests that the controlling of NSC dif-bilization help direct the earliest steps of neuronal differentiation.
ferentiation is crucial for a successful cell therapy. More extensive preclinical studies in stem cell biology will CONCLUSION provide compelling evidence to support cell therapy in the CNS diseases in the future. Transplantation of NSCs has been anticipated for its high potential for the treatments of CNS diseases even REFERENCES though several problems remain to be resolved: 1) how
